Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bausch Health Companies Inc shares valued at $3,674 were sold by Carson Seana on Dec 02 ’24. At $8.35 per share, Carson Seana sold 440 shares. The insider’s holdings dropped to 433,066 shares worth approximately $3.18 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Carson Seana purchased 440 shares, netting a total of over 3,674 in proceeds.
Before that, Carson Seana had sold 13,370 shares from its account. In a trade valued at $83,028, the EVP, General Counsel traded Bausch Health Companies Inc shares for $6.21 each. Upon closing the transaction, the insider’s holdings decreased to 13,370 shares, worth approximately $3.19 million.
As published in a research note from Piper Sandler on August 02, 2024, Bausch Health Companies Inc [BHC] has been rated down from a Neutral to an Underweight and the price target has been revised to $3 from $9. Analysts at Raymond James started covering the stock with ‘”a Mkt perform”‘ outlook in a report released in early July. As of September 20, 2023, Jefferies has increased its “Hold” rating to a “Buy” for BHC. Earlier on June 16, 2023, TD Cowen downgraded its rating. Their new recommendation was “a Market perform” for BHC stock which previously was a “an Outperform”.
Analyzing BHC Stock Performance
During the last five days, there has been a drop of approximately -3.17%. Over the course of the year, Bausch Health Companies Inc shares have dropped approximately -8.48%. Shares of the company reached a 52-week high of $11.46 on 04/03/24 and a 52-week low of $3.96 on 07/24/24. A 50-day SMA is recorded $8.35, while a 200-day SMA reached $7.63. Nevertheless, trading volume fell to 1.57 million shares from 0.48 million shares the previous day.
Support And Resistance Levels for Bausch Health Companies Inc (BHC)
According to the 24-hour chart, there is a support level at 7.18, which, if violated, would cause prices to drop to 7.03. In the upper region, resistance lies at 7.64. The next price resistance is at 7.95. RSI (Relative Strength Index) is 35.72 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.39, which suggests the price will decrease in the coming days. Percent R is at 99.16%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
